SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-362102"
 

Search: onr:"swepub:oai:DiVA.org:uu-362102" > External Validation...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Ueda, PeterKarolinska Institute,Karolinska Institutet,Karolinska Inst, Sweden (author)

External Validation of the DAPT Score in a Nationwide Population

  • Article/chapterEnglish2018

Publisher, publication year, extent ...

  • ELSEVIER SCIENCE INC,2018
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-362102
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-362102URI
  • https://doi.org/10.1016/j.jacc.2018.06.023DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:139024203URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-151186URI
  • https://lup.lub.lu.se/record/ca48f84a-495b-496b-904d-073b554e62e2URI
  • https://gup.ub.gu.se/publication/270851URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|Stiftelsen for alderssjukdomar, Karolinska Institutet; AstraZeneca; Janssen; Bayer; Medicines Company; Novartis; Merck; Sanofi; Abbott
  • BACKGROUND The dual antiplatelet therapy (DAPT) score guides decisions on DAPT duration after coronary stenting by simultaneously predicting ischemic and bleeding risk. OBJECTIVES This study sought to assess the performance of the DAPT score in a nationwide real-world population. METHODS The study used register data in Sweden (2006 to 2014) and followed 41,101 patients who had undergone 12 months of event-free DAPT, from months 12 to 30 after stenting. Risk of myocardial infarction (MI) or stent thrombosis, major adverse cardiovascular and cerebrovascular events (MACCE) (MI, stroke, and all-cause death), and fatal or major bleeding were compared according to DAPT score. RESULTS The score had a discrimination of 0.58 (95% confidence interval [CI]: 0.56 to 0.60) for MI or stent thrombosis, 0.54 (95% CI: 0.53 to 0.55) for MACCE, and 0.49 (95% CI: 0.45 to 0.53) for fatal or major bleeding. Risk of MI or stent thrombosis was significantly increased at scores of >= 3 while MACCE risk followed a J-shaped pattern and increased at scores of >= 4. Absolute differences in fatal or major bleeding risk were small between scores. Event rates of ischemic and bleeding outcomes in patients with high (>= 2) and low (< 2) scores differed compared to the DAPT Study from which the score was derived; fatal or major bleeding rates were approximately one-half of those in the placebo arm of the DAPT Study. CONCLUSIONS In a nationwide population, the DAPT score did not adequately discriminate ischemic and bleeding risk, the relationship between score and ischemic risk did not correspond to the suggested decision rule for extended DAPT, and risk of bleeding was lower compared with the DAPT Study. The score and its decision rule may not be generalizable to real-world populations.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Jernberg, TomasKarolinska Institute,Karolinska Institutet,Karolinska Inst, Sweden,Danderyd Hospital (author)
  • James, Stefan K,1964-Uppsala University,Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR),Uppsala Univ, Sweden(Swepub:uu)stjam367 (author)
  • Alfredsson, JoakimLinköping University,Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US(Swepub:liu)joaal38 (author)
  • Erlinge, DavidLund University,Lunds universitet,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Molecular Cardiology,Lund University Research Groups,Skåne University Hospital(Swepub:lu)kard-der (author)
  • Omerovic, Elmir,1968Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine(Swepub:gu)xomeel (author)
  • Persson, JonasKarolinska Institute,Karolinska Institutet,Karolinska Inst, Sweden,Danderyd Hospital (author)
  • Ravn-Fischer, Annica,1974Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine(Swepub:gu)xravan (author)
  • Tornvall, PerKarolinska Institute,Karolinska Institutet,Karolinska Inst, Sweden,Stockholm South General Hospital (author)
  • Svennblad, BodilUppsala University,Uppsala universitet,Ortopedi,Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden,Epihubben(Swepub:uu)bosve677 (author)
  • Varenhorst, Christoph,1977-Uppsala University,Uppsala universitet,Kardiologi,Pfizer AB, Sollentuna, Sweden,Uppsala Univ, Sweden; Pfizer AB, Sweden,Pfizer Inc. US(Swepub:uu)chrva923 (author)
  • Karolinska InstitutetKarolinska Inst, Sweden (creator_code:org_t)

Related titles

  • In:Journal of the American College of Cardiology: ELSEVIER SCIENCE INC72:10, s. 1069-10780735-10971558-3597

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view